IDH proposing to delist its shares from the Egyptian Exchange
(Cairo and London) — Integrated Diagnostics Holdings plc (“IDH”, the “Company” or the “Group”), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, Nigeria and Saudi Arabia, today announces that the directors of the Company (the “Board” or the “Directors”) have decided to proceed with a proposed voluntary delisting of the Company’s ordinary shares (the “Shares”) from the Egyptian Exchange (the “EGX”) (the “EGX Delisting”).